CRISPR Therapeutics AG (CRSP) — Net Income

Annual figures by fiscal year, from SEC filings.

2014: -$7.01M2015: -$25.50M2016: -$23.18M2017: -$68.36M2018: -$164.98M2019: $66.86M2020: -$348.87M2021: $377.66M2022: -$650.17M2023: -$153.61M2024: -$366.25M2025: -$581.60M-$581.60M
2014Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$581.60M-58.8%
2024-$366.25M-138.4%
2023-$153.61M+76.4%
2022-$650.17M-272.2%
2021$377.66M+208.3%
2020-$348.87M-621.8%
2019$66.86M+140.5%
2018-$164.98M-141.4%
2017-$68.36M-194.9%
2016-$23.18M+9.1%
2015-$25.50M-263.9%
2014-$7.01M